Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,448
Total Claims
$7.7M
Drug Cost
230
Beneficiaries
$33K
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
-13%
Opioid rate vs peers
5.5% vs 6.3% avg
+146%
Cost per patient vs peers
$33K vs $14K avg
Opioid Prescribing
5.5%
Opioid Rate
134
Opioid Claims
$9,286
Opioid Cost
17.9%
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 1,811 claims · $927K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Enzalutamide | 118 | $1.6M |
| Cabozantinib S-Malate | 58 | $1.4M |
| Apalutamide | 67 | $966K |
| Abiraterone Acetate | 214 | $799K |
| Axitinib | 41 | $785K |
| Darolutamide | 49 | $624K |
| Lenvatinib Mesylate | 22 | $512K |
| Olaparib | 15 | $235K |
| Relugolix | 53 | $137K |
| Everolimus | 11 | $98K |
| Apixaban | 73 | $43K |
| Sitagliptin Phosphate | 11 | $8,279 |
| Rivaroxaban | 11 | $6,395 |
| Oxycodone Hcl | 13 | $4,829 |
| Prednisone | 393 | $2,298 |
Prescribing Profile
Patient Profile
74
Avg Age
21%
Female
2.67
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About